The following is a summary of "Sex differences in outcomes in patients with acute myocardial infarction," published in the ...

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within ...

For patients with asymptomatic or symptomatic carotid stenosis of 50 percent or greater with a low or intermediate predicted ...

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial, according to ...

New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder ...

The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse ...

Patients hospitalized for heart failure who have cannabis use disorder (CUD) are significantly more likely to experience ...

BACKGROUND: Elevated plasma levels of Lp(a) [lipoprotein(a)] are a causal risk factor for coronary heart disease and stroke ...

Febuxostat does not appear to increase the risk for major adverse cardiovascular events when compared with no urate-lowering ...